Company: PFSA
Filing Date: 2025-10-29
Form Type: 424B3
Source: 0001213900-25-103174
Chunk: 308

Company: Profusa, Inc.
Filing Date: 2025-10-29
Form: 424B3
Chunk 308
---
,701 |   |
| Series C/C-1 convertible preferred stock: $0.0001 par value – 8,907,893 shares authorized at June 30, 2025 and December 31, 2024, and 8,220,445 shares issued and outstanding at June 30, 2025 and December 31, 2024, (Liquidation preference $45,062 at June 30, 2025 and December 31, 2024) |     |   |      46,217 |   |     |   |      46,217 |   |
| Total convertible preferred stock                                                                                                                                                                                                                                                             |     |   |      65,149 |   |     |   |      65,149 |   |
| Stockholders’ deficit:                                                                                                                                                                                                                                                                        |     |   |             |   |     |   |             |   |
| Common stock: $0.0001 par value – 40,000,000 authorized shares at June 30, 2025                                                                                                                                                                                                               
 and December 31, 2024, and 5,604,651 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively                                                                                                                                                                       |     |   |           — |   |     |   |           — |   |
| Additional paid-in-capital                                                                                                                                                                                                                                                                    |     |   |       5,840 |   |     |   |       5,753 |   |
| Accumulated deficit                                                                                                                                                                                                                                                                           |     |   |    (130,022 | ) |     |   |    (124,958 | ) |
| Total stockholders’ deficit                                                                                                                                                                                                                                                                   |     |   |    (124,182 | ) |     |   |    (119,205 | ) |
| Total liabilities, convertible preferred stock and stockholders’ deficit                                                                                                                                                                                                                      |     | $ |       4,444 |   |     | $ |       3,073 |   |

<div align='center'>The accompanying notes are an integral part of
these condensed consolidated financial statements.

F-30

PROFUSA, INC. AND SUBSIDIARY
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(UNAUDITED)
(IN THOUSANDS, EXCEPT SHARE AND PER SHARE AMOUNTS)</div>

|                                                                                                                                                                                                                                |     | 2025 | Three Months Ended 
           June 30, |